BMRN vs EXEL
BioMarin Pharmaceutical vs Exelixis — AI-powered side-by-side comparison
| Metric | BMRN | EXEL |
|---|---|---|
| AI Score | 48 | 59 |
| Price | $59.60 | $55.91 |
| P/E Ratio | 42.56× | 17.92× |
| ROE | 0.1% | 0.4% |
| Revenue Growth YoY | — | — |
| Gross Margin | 0.8% | 1.0% |
| Debt / Equity | 0.23× | 0.09× |
| Dividend Yield | 0.0% | 0.0% |
| RSI (14) | 59.1 | 57.2 |
| Beta | 0.239 | 0.424 |
| Expected Upside | +6.9% | — |
Want the full breakdown?
Committee votes, technicals, and trade plans for both companies.
BMRN Full Analysis
EXEL Full Analysis